Nooms program is deliberately designed to counteract present bias by providing immediate, positive reinforcement for healthy actions
Neeland IJ, McGuire DK, Sattar N
In a single center, double blinded, randomized controlled clinical trial, Ismail et al
GLP-1 agonist medications are thought to help with weight loss in the following ways: Increase the amount of natural insulin available in the body, helping to move sugar from the blood Slow the movement of food content through the stomach, causing you to feel fuller longer Tell your brain that you are full, which leads to a reduced appetite and consuming fewer calories One study found that the average weight loss difference between people who received GLP-1s and those who received a placebo drug was 4% to 6.5% in people with type 2 diabetes and 6.1% to 17.4% in people without diabetes
Novartis Found Symp 285 , 229243, discussion 243246 (2007)
How do you reconstitute CJC-1295 (no DAC) + Ipamorelin